Glaukos Corporation
GKOS
Classement en actions
#2023
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Prix de l'action
$174.03
Capitalisation boursière
$10.26B
Changement (1 jour)
4.34%
Changement (1 an)
118.99%
Pays
US
Échange Glaukos Corporation (GKOS)
Catégorie
Healthcare
Nombre d'actions en circulation pour Glaukos Corporation (GKOS)
Nombre d'actions en circulation au June 2026: 58.42M
Selon les derniers rapports financiers et le cours de l'action de Glaukos Corporation, le nombre actuel d'actions en circulation est de 58.42M. À la fin de December 2023, l'entreprise avait 48.43M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Glaukos Corporation (GKOS) de 2012 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 58.42M | 10.74% |
| 2024 | 52.76M | 8.92% |
| 2023 | 48.43M | 2.08% |
| 2022 | 47.44M | 2.20% |
| 2021 | 46.42M | 4.33% |
| 2020 | 44.50M | 19.12% |
| 2019 | 37.36M | 6.72% |
| 2018 | 35.00M | 1.81% |
| 2017 | 34.38M | 4.41% |
| 2016 | 32.93M | 88.44% |
| 2015 | 17.47M | -29.78% |
| 2014 | 24.89M | 0.00% |
| 2013 | 24.89M | 1,153.02% |
| 2012 | 1.99M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 1.74B | 2,883.70% |
US
|
|
| 1.28B | 2,094.66% |
IE
|
|
| 383.50M | 556.46% |
US
|
|
| 1.48B | 2,429.31% |
US
|
|
| - | - |
DE
|
